KLK3 and cancer: Heijnsdijk et al23 estimated that 5% fewer overdiagnosed cancers would be detected through the use of PHI compared with PSA, and Karlsson et al27 predicted 15% fewer overdiagnosed cancers through the use of Stockholm3 when PSA values were above 2 ng/mL compared with PSA alone.